Navigation Links
Transplant drug 2-year study outcomes show superior kidney function
Date:5/2/2010

SAN DIEGOTwo-year results from phase III clinical trials show the experimental immunosuppressive drug belatacept can better preserve kidney function in kidney transplant recipients while preventing graft rejection when compared with the standard immunosuppressive drug cyclosporine.

The two-year results from the three-year BENEFIT (Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial) and BENEFIT-EXT ("extended criteria") studies were presented Sunday at the American Transplant Congress in San Diego. A safety study that pooled long- term data also was presented.

In the BENEFIT trial, 666 patients were randomized to three groups and transplanted at 100 sites around the world, with 493 completing two years on treatment. In the BENEFIT-EXT study, 543 patients were randomized and transplanted, with 347 completing two years on treatment. The three treatment groups were less intensive (LI) and more intensive (MI) belatacept and a standard regimen of cyclosporine (CsA). All patients also received standard transplant regimens of the anti-T cell antibody basiliximab and drugs mycophenolate mofetil and corticosteroids.

Patient and graft survival after two years was similar among the belatacept and cyclosporine groups (94 percent MI; 95 percent LI; 91 percent CsA). The superior renal benefit of belatacept found after the first year of treatment was sustained in the second year, as measured by glomerular filtration rate. The improvement in cardiovascular/metabolic risk profile with belatacept remained in year two, with an additional beneficial effect noted in LDL cholesterol. Eight additional patients experienced an episode of acute rejection in year two (four with belatacept, four with cyclosporine), but in most cases this was successfully treated with drugs and did not lead to graft failure.

The overall incidence rate of malignancies and serious infections remained comparable across the groups.
'/>"/>

Contact: Kathi Baker
kobaker@emory.edu
404-727-9371
Emory University
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Study shows liver transplant center impacts patient outcomes
2. Extended hepatitis C treatment after liver transplant may benefit patients
3. Cancer risk for kidney transplant
4. Cancer Risk After Kidney Transplant Unaffected by Type of Drug Treatment
5. Study examines global availability of treatment involving transplantation of blood stem cells
6. Cedars-Sinai heart transplantation tip sheet
7. Cell Transplantation Eyed as Treatment for Cerebral Palsy
8. Wounded Soldier Spared Diabetes With Emergency Transplant
9. Human development index linked to stem cell transplant rates and success in leukemia patients
10. Corneal Transplant Not Hurt by Long Preservation Time
11. Nu/Hart Leads The Way With Revolutionary Hair Transplant Procedure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Tampa, FL (PRWEB) December 19, 2014 ... Celliant Revitalizing Bedsheets are now available. Celliant, the ... in both sheets and pillowcases. , There are ... clinically proven additional circulation, increased oxygenation and balanced ... quality, faster healing and pain relief; enhanced athletic ...
(Date:12/19/2014)... Santa Rosa, CA (PRWEB) December 19, 2014 ... 2x4 and 5x5 SuperClone Rooms. SuperCloset continues to offer ... grow solutions. Pair one of the new SuperClone Rooms ... truly professional, perpetual, and turnkey indoor hydroponic grow room ... cloner in the world, SuperCloset’s SuperPonic SuperCloner 50 ...
(Date:12/19/2014)... An evening dress is perfect for any occasion ... a distinguished dresses retailer, has unveiled its new selection of ... this great shopping platform. Customers can view more ... Discount-Dress.com has been accepted and praised by customers for many ... stage for clients. In order to expand its market share, ...
(Date:12/19/2014)... warns parents that buying an older car for their teens may ... drivers killed in the United States between 2008 and 2012 were ... lacked important safety features that are available on newer cars, the ... were in cars at least six years old, 34 percent were ... cars 11 to 15 years old, and 17 percent were in ...
(Date:12/19/2014)... (HealthDay News) -- Potentially illness-causing E. coli bacteria were ... markets, according to a new study. Researchers checked ... 13 farmers markets in Los Angeles and Orange counties ... almost 150 samples tested, 24 percent were positive for ... to the researchers. Both types of bacteria can ...
Breaking Medicine News(10 mins):Health News:Energy Textiles Launches Celliant Revitalizing Bedsheets 2Health News:SuperCloset Continues to Innovate with New Complete Indoor Grow Room Packages, The SuperClone Rooms are the Newest Addition to the Award Winning SuperRoom Lineup 2Health News:Attractive Evening Dresses Announced by Discount-Dress.com 2Health News:Older Cars a Bad Choice for Younger Drivers 2Health News:E. Coli Germs Found on Farmers Market Herbs 2
... Calif., Sept. 17 The Los Angeles,Area Chamber ... proposal which includes a 4 percent payroll fee ... not already contribute at least that much,to providing ... Chamber,Board of Directors urged Governor Schwarzenegger and other ...
... Offices of Howard G.,Smith announces that a securities class ... purchased the common stock of LCA-Vision Inc.,("LCA-Vision" or the ... July 30, 2007 (the "Class Period"). The class action ... the Southern District of Ohio. The Complaint alleges ...
... Expanded Solutions to Medical Device and,Diagnostics Industries, ... (SBI),announced today that it has entered into a ... (Popper). Popper supplies a variety of specialty,needle and ... The combination will create the world,s leading cutting ...
... N.J., Sept. 17 Akers Biosciences,Inc. (LSE: AKR) ... screening and testing products, is pleased to announce ... States Army for the purchase of its,BreathScan alcohol ... and,is deliverable beginning immediately. The Company has ...
... in National Clean Hands Week survey-, PHILADELPHIA, Sept. ... Coalition,s "Cleanest Hands in America" survey,residents of the Philadelphia ... hygiene practices of individuals living in the U.S. top ... ranked #23 ... one above,Portland, OR #24 and two ...
... A new study by researchers at the University of Southern ... , Researchers found that a storyline on the primetime ... and healthy eating habits had a positive impact on the ... study, published in the Sept. 14 Journal of Health Communication ...
Cached Medicine News:Health News:Los Angeles Area Chamber of Commerce Endorses Governor Schwarzenegger's Health Care Proposal 2Health News:Akers Biosciences, Inc. 'ABI' or the 'Company' Receipt of Further United States Military Contracts 2Health News:ER episode impacts viewers' health knowledge and behavior 2
(Date:12/17/2014)... December 17, 2014 Revenue and earnings ... on research and development In the past 2013/14 ... by two percent to EUR 4.287 billion (last year: EUR ... 14 percent to EUR 360 million. "Overall, 2013/14 was a ... Michael Kaschke , President and CEO of Carl Zeiss AG. ...
(Date:12/17/2014)... , Dec. 17, 2014 With ... (MRI), the MRI market is seeing new growth, ... breast MRI scans account for the majority of ... higher resolution of images, which are creating opportunities for ... (MRI) market is growing at a rate of ...
(Date:12/17/2014)... , Dec. 17, 2014  ImmunoCellular Therapeutics, Ltd. ... Patent and Trademark Office (USPTO) has issued a ... dendritic cell-based immunotherapeutic vaccine targeting six tumor antigens ... of US Patent No. 8,871,211, which issued October ... by administering a dendritic cell composition comprising peptide ...
Breaking Medicine Technology:ZEISS Asserts its Position in Difficult Environment 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2
... SAN DIEGO, March 30, 2011 Neurocrine Biosciences, Inc. (Nasdaq: ... and Chief Executive Officer of Neurocrine Biosciences, will be presenting ... City.   The live presentation takes place ... / 10:20 a.m. Pacific Time.  The presentation will be webcast ...
... AAIPharma Services Corp., a leading provider of ... its compendial raw materials testing group to a ... Wilmington, N.C., headquarters facility. The move follows a ... analytical testing business. (Logo:   http://photos.prnewswire.com/prnh/20110330/CG74146LOGO ...
Cached Medicine Technology:AAIPharma Services Announces Compendial Testing Facility Expansion 2
... including the Ceralas D and SmilePro 980 ... medical, dental, and veterinary environments.,With unsurpassed, optimal ... nm laser series allow controlled tissue ablation ... surgical procedures. Unlike other medical lasers, biolitecs ...
... The lightweight and portable AccuPach V Pachymeter ... touch screen and a synthesized voice that announces ... probe, and the unit has an optional printer ... can enter measured intraocular pressure into the unit ...
... GonoGen™ II is a monoclonal antibody ... confirmatory identification of Neisseria gonorrhoeae. The ... to run with no heating or ... isolated, viable or fresh cultures. GonoGen&trade ...
... GonoGen™ is a monoclonal ... for the confirmatory identification of ... not require isolated, viable or ... specimen and two minute rotation, ...
Medicine Products: